medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2005, Number 5

<< Back Next >>

Rev Invest Clin 2005; 57 (5)

Factors related to subjective evaluation of quality of life of diabetic patients

Árcega-Domínguez A, Lara-Muñoz C, Ponce-de-León-Rosales S

Language: Spanish
References: 37
Page: 676-684
PDF size: 73.41 Kb.


ABSTRACT

Objective. To determine the relationship between some clinical and psychosocial factors and the quality of life of a group of diabetic patients. Method. A cross sectional study was done with diabetic patients attending a primary care unit. Quality of life was evaluated with a verbal global scale. The clinical and psychosocial factors studied were: type of diabetes, duration of the disease, type of treatment, associated diseases, complications, metabolic control (glycosylated hemoglobin), treatment compliance, coping styles, negative attitude to disease, social support, and socioeconomical level. Results. We interviewed 173 patients, most women (73%), most type 2 (95%). We found that being a woman was a factor negatively related to quality of life. Of clinical variables, only duration of disease was slightly correlated with quality of life (-0.14). Psychological and social variables were significantly correlated with quality of life. We performed a stepwise multiple regression analysis and we found that seven psychosocial variables explained 30% of variance of quality of life. Conclusions. Our results indicate that clinical factors did not correlate with quality of life. It is the way the patient lives with diabetes and not the diabetes by itself what affects the quality of life of diabetic patients. Some psychological and social variables were significantly related to quality of life of these patients.


REFERENCES

  1. Vázquez RM. Prevalencia de diabetes mellitus no insulino-dependiente y factores de riesgo asociados en una población de México. Gac Med Mex 1993; 129: 191-9.

  2. Guerrero RJ, Rodriguez MM. Diabetes mellitus: un análisis de mortalidad por causa básica. Rev Med IMSS 1996; 34(1): 43-8.

  3. Escobedo de la Peña J. Incidencia y letalidad de las complicaciones agudas y crónicas de la diabetes mellitus en México. Salud Pública Mex 1996; 38: 236-42.

  4. Vázquez RM. Análisis de la mortalidad por diabetes mellitus en el Instituto Mexicano del Seguro Social (1979-1987). Rev Med IMSS 1990; 28: 157-69.

  5. González VC, Stern MP, Arredondo PB. Utilización de servicios hospitalarios por pacientes diabéticos: estudio en población abierta. Salud Pública Méx 1994; 36: 415-19.

  6. Aguilar Salinas CA, Gomez Perez FJ, Rull JA. Limitations of the diagnostic criteria for type 2 diabetes and glucose intolerance. Rev Invest Clín 2000; 52(2): 177-84.

  7. Schmitz O, Brock B, Rungby J. Amylin agonists: a novel approach in the treatment of diabetes. Diabetes 2004; 53(Suppl. 3): S233-8. S238.

  8. Barroso I. Genetics of Type 2 diabetes. Diabet Med 2005; 22(5): 517-35.

  9. Garay-Sevilla ME, Malacara JM, Gonzalez-Contreras E, Wrobel-Zasada K, Wrobel-Kaczmarczyk K, Gutierrez-Roa A. Perceived psychological stress in diabetes mellitus type 2. Rev Invest Clín 2000; 52(3): 241-5.

  10. Lara-Muñoz C, Feinstein AR. How should quality of life be measured? J Investigative Med 1999; 47(1): 17-24.

  11. Lara Muñoz MC, Ponce de Leon SE, De la Fuente JR. Conceptualización y medición de la calidad de vida de pacientes con cáncer. Rev Invest Clin 1995; 47: 315-27.

  12. Gill TM, Feinstein AR. A Critical Appraisal of the Quality of Life Measurements. JAMA 1994; 272: 619-26.

  13. Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. Medical Care 1997; 35(5): 440-53.

  14. Anonymous. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care 1988; 11(9): 725-32.

  15. Zetina-Lopez A, Custodio-Vazquez A, Hinojosa C, Juarez-Paiz L, Schmulson M. Impact of gastrointestinal symptoms on health related quality of life in patients with type 2 diabetes mellitus. Rev Invest Clín 2003; 55(6): 594-9.

  16. Taylor B, Foster B, Kyne-Grzebalski D, Vanderpump M. Insulin regimens for the non-insulin dependent: Impact on diurnal metabolic state and quality of life. Diabetic Medicine 1994; 11: 551-7.

  17. Katz MH. Multivariable analysis. A practical guide for clinicians. Cambridge University Press, 2002.

  18. Lara MMC. Conceptualización y medición de la calidad de vida de los pacientes con cáncer. Tesis doctoral. Universidad Nacional Autónoma de México 1997.

  19. Bronfman M, Guiscafre H, Castro V, Castro R, Gutiérrez G. La medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med (Mex.) 1988; 19: 351-9.

  20. Pérez SLM. Apego terapéutico y control metabólico en el paciente diabético. Tesis de posgrado. Universidad Nacional Autónoma de México 1997.

  21. Welch GW. The diabetes coping measure: a measure of cognitive and behavioural coping specific to diabetes (Appendix 2: newly designed scales). In: Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Bradley C, Ed. London: Harwood Academic 1994; 391-404.

  22. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care 1997; 20: 760-6.

  23. Lara MC, Arcega DA, Romero OT, Soriano AS. Características Psicométricas del Cuestionario de Impacto Emocional de la Diabetes. Psiquiatría 2002; 18: 127-30.

  24. Kemmer FW, Berger M. Therapy and better quality of life: the dichotomous role of exercise in diabetes mellitus. Diabetes/Metabolism Reviews 1986; 2: 53-68.

  25. Whoqol Group. Development of the WHOQOL: Rationale and Current Status. Int J Ment Health 1994; 23: 24-56.

  26. García P, Reyes MH, Garduño EJ, Fajardo GA, Martínez GC. La calidad de vida en el paciente diabético tipo 2 y factores relacionados. Rev Med IMSS (Mex.) 1995; 33: 293-8.

  27. Lopez-Carmona JM, Ariza-Andraca CR, Rodriguez-Moctezuma JR, Munguia-Miranda C. Development and initial validation of an instrument to measure the lifestyles of type 2 diabetes mellitus patients. Salud Pública de México 2003; 45(4): 259-68.

  28. Parkerson GR, Connis RT, Broadhead WE, Patrick DL, Taylor TR, Tse CJ. Disease-specific versus generic measurement of Health-related Quality of Life in insulin-dependent diabetic patients. Medical Care 1993; 31: 629-39.

  29. Keinänen-Kiukaanniemi S, Ohinmaa A, Pajunpaa H, Koivukangas P. Health related quality of life in diabetic patients measured by the Nottingham health profile. Diabetic Medicine 1996; 13: 382-8.

  30. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults whit diabetes. Diabetes Care 1997; 20: 562-7.

  31. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17: 267-74.

  32. Weinberger M, Kirkman S, Samsa GP, Cowper PA, Shortliffe EA, Simel DL, Feussner JR. The relationship between glycemic control and health related quality of life in patients with non insulin dependent diabetes mellitus. Med Care 1994; 29: 1173-81.

  33. The diabetes control and complications trial research group (DCCT). Influence of intensive diabetes treatment on quality of life outcomes in the diabetes control and complications trial. Diabetes Care 1996; 19: 195-203.

  34. Johnson JA, Nowatzki TE, Coons SJ. Health-related quality of life of diabetic pima indians. Med Care 1996; 34: 97-102.

  35. Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS. The sickness impact profile: validation of a health status measure. Med Care 1976; 14: 57-67.

  36. Hanninen JA. Depression in subjects with type 2 diabetes: predictive factors and relation to quality of life. Diabetes Care 1999; 22(6): 997-8.

  37. Feinstein AR. Clinimetrics. New Haven: Yale University Press; 1997.




2020     |     www.medigraphic.com